KGN +50.16%: shares in eCommerce business Kogan.com surged to 3-month highs today on the back of better-than-expected performance in the business. Sales for FY22 are expected to come in marginally above the prior year, beating out expectations of a fall from the COVID-supported growth of FY21. While sales are up, EBTIDA is expected to fall to $19.1m, which is still a small beat to consensus. Impressively they have managed to reduce inventory levels from $228m down to $161m, which includes $22m already in transit. Warehousing costs had been an issue for Kogan with inventories blowing out requiring expensive overflow capacity. Importantly it appears stock has been moved without the need for significant discounting.
scroll
Question asked
Question asked
Question asked
Eli Lilly & Co (LLY US) v Novo Nordisk (NVO US)
Close
PULSE CHECK WEBINAR: Portfolio positioning towards FY26
Close
Gerrish: The correction is done, we’re positioning for what comes next
Close
Friday 6th June – Dow off -108pts, SPI down -13pts
Close
A better than feared sales update from KGN
Add To Hit List
Related Q&A
What stocks would we top up here?
MM views on Qantas (QAN) & Kogan (KGN)
Our view on 3 online retailers
Relevant suggested news and content from the site


chart
Eli Lilly & Co (LLY US) v Novo Nordisk (NVO US)

Video
WATCH
PULSE CHECK WEBINAR: Portfolio positioning towards FY26
FY26 is shaping up as a year where strategic portfolio positioning will matter more than ever. Hear from James Gerrish & Shawn Hickman as they detail MM's current views.

Video
WATCH
Gerrish: The correction is done, we’re positioning for what comes next
The Market Matters lead portfolio manager talks the recent recovery, Trump, gold, and why he thinks there's plenty of opportunities.

Podcast
LISTEN
Friday 6th June – Dow off -108pts, SPI down -13pts
Daily Podcast Direct from the Desk
Members only
UNLOCK MARKET MATTERS NOW
Take a free trial.
No payment details required.